UCSD BEACON Congratulates First 2026 Pilot Award Recipients!
Development and Evaluation of Reflex Lp(a) Testing in Patients with Peripheral Artery Disease
Lipoprotein(a) in pregnancy: Associations with preeclampsia and differences across gestation
Development and Evaluation of Reflex Lp(a) Testing in Patients with Peripheral Artery Disease
Elsie G. Ross, MD, MS, RPVI, FAHA
Despite the availability of important cardiovascular risk factor testing, many patients with peripheral artery disease never receive it. This creates missed opportunities for targeted prevention and treatment. This study aims to address this gap by leveraging health informatics and institutional partnerships to build automated, sustainable testing pathways directly into clinical workflows.
Working collaboratively with UC San Diego Health's clinical informatics and population health teams, this project integrates diagnostic data sources with the electronic health record to trigger guideline-recommended testing at clinically relevant moments, aiming to do so with minimal additional burden on providers or patients. The approach is designed to be equitable by design, reducing reliance on individual provider awareness and reaching populations who have historically been undertested.
The pilot will generate foundational infrastructure and preliminary data to support a larger, multi-site implementation study aimed at closing persistent gaps in cardiovascular care.
Lipoprotein(a) in pregnancy: Associations with preeclampsia and differences across gestation
Marni Jacobs, PhD, MPH
This project aims to characterize Lp(a) in pregnancy with a primary focus on identifying differences in Lp(a) among those with a hypertensive disorder of pregnancy (HDP) compared to those who remain normotensive.
Preeclampsia and other hypertensive disorders of pregnancy are a leading cause of both maternal and neonatal morbidity, and are strong independent risk factors for maternal cardiovascular disease years after pregnancy. Increased lipid levels have been reported in patients with preeclampsia, yet, despite lipoprotein(a) being recognized as a substantial independent risk factor for cardiovascular disease, associations between Lp(a) and preeclampsia remain understudied and poorly understood.
This project will use samples from an existing obstetric biobank linked with detailed clinical outcomes to characterize Lp(a) in patients with and without HDP, both around the time of delivery and longitudinally.
We are very excited to continue these projects with Drs. Ross and Jacobs to push the envelope in our understanding of Lp(a). Thank you to all who applied, and we look forward to next year's proposals.